EMCDDA continues support for EU drug-related regional programme in Central Asia
, rubrika EMCDDA news
The Central Asian Drug Action Programme (CADAP), is currently in its sixth phase and reflects the EU’s long-term engagement with Central Asian partners to help further strengthen their national policies in drug demand reduction.
22.02.2018
